S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 aTyr PharmaPharmaCyte BiotechPolarityTEMosaic ImmunoEngineeringBiondVax Pharmaceuticals
SymbolNASDAQ:LIFEOTCMKTS:PMCBNASDAQ:PTEOTCMKTS:CPMVNASDAQ:BVXV
Price Information
Current Price$4.35$0.03$1.29$3.62$3.98
52 Week RangeBuyN/ABuyN/AN/A
MarketRank™
Overall Score1.50.51.40.30.5
Analysis Score3.50.03.30.00.0
Community Score2.32.42.70.02.5
Dividend Score0.00.00.00.00.0
Ownership Score0.80.00.01.70.0
Earnings & Valuation Score0.60.01.30.00.0
Analyst Ratings
Consensus RecommendationBuyN/ABuyN/AN/A
Consensus Price Target$12.00N/A$4.00N/AN/A
% Upside from Price Target175.86% upsideN/A210.08% upsideN/AN/A
Trade Information
Market Cap$44.31 million$64.86 million$77.57 million$2.92 million$45.19 million
Beta2.170.491.291.972.41
Average Volume1,252,25225,395,91412,731,9381,3751,534,838
Sales & Book Value
Annual Revenue$420,000.00N/A$5.65 millionN/AN/A
Price / Sales105.49N/A13.73N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.40 per shareN/A$1.42 per share$0.79 per share($2.88) per share
Price / Book0.81N/A0.91N/AN/A
Profitability
Net Income$-23,600,000.00$-3,830,000.00$-92,490,000.00$-1,060,000.00$-31,600,000.00
EPS($7.03)N/A($3.70)N/A($3.60)
Trailing P/E RatioN/A0.00N/A0.00N/A
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-202.02%N/A-674.12%N/AN/A
Return on Equity (ROE)-52.75%-57.82%-169.92%-302.22%N/A
Return on Assets (ROA)-38.40%-49.63%-105.62%-128.52%-135.18%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.08%N/AN/A
Current Ratio4.76%5.92%3.22%0.56%6.48%
Quick Ratio4.76%5.92%3.11%0.56%6.48%
Ownership Information
Institutional Ownership Percentage55.82%0.02%16.51%0.13%4.04%
Insider Ownership Percentage9.44%N/A5.50%72.93%6.03%
Miscellaneous
Employees394153N/A25
Shares Outstanding10.19 million2.34 billion60.13 million806,00011.35 million
Next Earnings Date3/25/2021 (Estimated)3/12/2021 (Estimated)3/11/2021 (Estimated)3/4/2021 (Estimated)6/11/2021 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.